U.S. markets closed

Empower Clinics Inc. (CBDT.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.5300-0.0400 (-7.02%)
At close: 3:59PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5700
Bid0.5200 x 0
Ask0.5300 x 0
Day's Range0.5100 - 0.5800
52 Week Range0.0300 - 2.5000
Avg. Volume7,812,103
Market Cap104.009M
Beta (5Y Monthly)3.64
PE Ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings DateAug 14, 2019 - Aug 15, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more

      Empower Clinics Hits Critical Milestone for KAI Laboratory Expansion, Celebrates Continued Patient Growth

      KAI LAB now weeks away from its grand opening VANCOUVER, BC / ACCESSWIRE / May 4, 2021 / EMPOWER CLINICS INC. (CBDT: CSE) (8EC: Frankfurt) (EPWCF: OTCQB) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that as of today, the expansion to triple the size of Kai Laboratory officially hit its halfway mark.


      Empower Clinics Annouces Approval of Management Cease Trade Order

      VANCOUVER, BC / ACCESSWIRE / May 3, 2021 / EMPOWER CLINICS INC.The Company recently announced it was filing an application seeking an MCTO from the BCSC after determining it would be unable to file its audited annual financial statements for the year ended December 31, 2020, and its related Management's Discussion and Analysis and Chief Executive Officer and Chief Financial Officer certifications (collectively, the "Required Filings"), by the prescribed filing deadline of April 30, 2021 (the "Filing Deadline").


      Empower Announces Delay in Filing of Annual Financial Statements

      VANCOUVER, BC / ACCESSWIRE / April 30, 2021 / Empower Clinics Inc.The delay is primarily due to the negative impact of the coronavirus pandemic and our inability to travel for audit purposes to our U.